Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia | NCT02248987 | Trialant
CompletedObservationalUpdated Apr 8, 2019
Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia
ClinicalTrials.gov ID
NCT02248987
Lead Sponsor
Seoul National University HospitalOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
36Actual
Last Update Posted
Apr 8, 2019Actual
Start Date
May 2014
Primary Completion Date
May 2016Actual
Completion Date
May 2016Actual
Brief Summary
The purpose of this study is to evaluate abnormal dopamine synthesis and connectivity according to the antipsychotic treatment response in schizophrenia.
Schizophrenia
patients treated with antipsychotics
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
diagnosis of schizophrenia
clinically stable state
Exclusion Criteria:
history of previous head injury, epileptic disorder, other medical comorbidity